best performing mid-cap stocks in may 2020

Oruka Therapeutics (ORKA) had the highest return in May 2020 by a mid-cap US stock, returning 254.9%.

ASSETMONTH% RETURN
Oruka Therapeutics (ORKA)
May 2020
254.93%
Protagonist Therapeutics (PTGX)
May 2020
148.57%
Hut 8 Corp Common Stock (HUT)
May 2020
100%
Penn National Gaming (PENN)
May 2020
97.06%
Enliven Therapeutics (ELVN)
May 2020
94.26%
Liquidia Technologies (LQDA)
May 2020
89.34%
Celsius (CELH)
May 2020
85.78%
United Natural Foods (UNFI)
May 2020
85.26%
Riot Platforms (RIOT)
May 2020
81.36%
Caesars Entertainment (CZR)
May 2020
79.82%
Ideaya Biosciences (IDYA)
May 2020
73.89%
Viridian Therapeutics (VRDN)
May 2020
73.13%
Wix (WIX)
May 2020
71.31%
Immunitybio (IBRX)
May 2020
70.63%
Celcuity LLC (CELC)
May 2020
61.9%
Beam Therapeutics  (BEAM)
May 2020
61.61%
TG Therapeutics (TGTX)
May 2020
61.19%
RH (RH)
May 2020
56.06%
Fortuna Silver Mines (FSM)
May 2020
55.36%
Acm Research (ACMR)
May 2020
55.3%
Tutor Perini (TPC)
May 2020
54.18%
Schrodinger (SDGR)
May 2020
51.24%
USA Compression Partners (USAC)
May 2020
49.88%
Appfolio (APPF)
May 2020
49.75%
Resideo Technologies (REZI)
May 2020
42.92%
Mid-cap stocks are treated as having a market cap between $2B and $10B.

Related Searches